Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet. 1997

K M Jensen, and S Mikkelsen
Dumex-Alpharma A/S, Copenhagen, Denmark.

The plasma profiles of nitroglycerin (glyceryl trinitrate, GTN, CAS 55-63-0) were estimated after two sublingual puffs of 0.4 mg GTN from a fluorochlorohydrocarbon (FCH)-free oral spray and one sublingual tablet of 0.5 mg GTN (Nitromex). The study was carried out in an open, randomized, two-phase, cross-over design with 24 volunteers. Eighteen blood samples were taken within 30 minutes after administration, and the plasma concentrations of GTN were determined by a specific gas chromatographic method with electron capture detection. The pharmacokinetic parameters, Cmax, tmax, and AUC, were determined for each volunteer. After correction of the AUC and Cmax values of the oral spray by dividing by two, the ratios (spray/tablet) of the AUC and Cmax and the 90% confidence intervals were estimated. The plasma concentrations of GTN (mean) after the spray (dose: 0.8 mg GTN) reached a maximum of 3.96 ng/ml (range: 0.99-10.86) at 3.5 minutes (range: 2-5). The plasma concentrations of GTN (mean) after the tablet (dose: 0.5 mg GTN) reached a maximum of 1.97 ng/ml (range: 0.57-4.33) at 4.9 minutes (range: 3-7). The corrected ratios (spray/tablet) of AUC and Cmax were 1.02 and 0.97 with the 90% confidence intervals (0.80, 1.30), respectively (0.77, 1.24). The results indicate that the oral spray in a dose of 0.4 mg is equivalent to the sublingual tablet in a dose of 0.5 mg.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

K M Jensen, and S Mikkelsen
November 1992, Drug and therapeutics bulletin,
K M Jensen, and S Mikkelsen
July 1991, Lancet (London, England),
K M Jensen, and S Mikkelsen
September 1986, The British journal of clinical practice,
K M Jensen, and S Mikkelsen
April 1985, The Australian nurses' journal. Royal Australian Nursing Federation,
K M Jensen, and S Mikkelsen
November 1984, British medical journal (Clinical research ed.),
K M Jensen, and S Mikkelsen
July 1988, BMJ (Clinical research ed.),
K M Jensen, and S Mikkelsen
January 1988, Arzneimittel-Forschung,
Copied contents to your clipboard!